Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Bonanni

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
ACS Medicinal Chemistry Letters|April 19, 2019
Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3Marco L Lolli, Irene M Carnovale, Agnese C Pippione, et al.
Journal of Medicinal Chemistry|July 23, 2025
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate CancerAndrea Citarella, Silvia Belluti, Davide Bonanni, et al.
Journal of Medicinal Chemistry|January 30, 2019
Correction to Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase InhibitorsStefano Sainas, Agnese C Pippione, Elisa Lupino, et al.
Journal of Medicinal Chemistry|June 26, 2018
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase InhibitorsStefano Sainas, Agnese C Pippione, Elisa Lupino, et al.
Journal of Medicinal Chemistry|April 12, 2021
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-<i>a</i>]pyridine Scaffold: SAR of the Biphenyl MoietyStefano Sainas, Marta Giorgis, Paola Circosta, et al.
Journal of Medicinal Chemistry|September 26, 2022
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-<i>a</i>]pyridine Scaffold: SAR of the Aryloxyaryl MoietyStefano Sainas, Marta Giorgis, Paola Circosta, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
ACS Medicinal Chemistry Letters|April 19, 2019
Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3Marco L Lolli, Irene M Carnovale, Agnese C Pippione, et al.
Journal of Medicinal Chemistry|July 23, 2025
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate CancerAndrea Citarella, Silvia Belluti, Davide Bonanni, et al.
Journal of Medicinal Chemistry|January 30, 2019
Correction to Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase InhibitorsStefano Sainas, Agnese C Pippione, Elisa Lupino, et al.
Journal of Medicinal Chemistry|June 26, 2018
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase InhibitorsStefano Sainas, Agnese C Pippione, Elisa Lupino, et al.
Journal of Medicinal Chemistry|April 12, 2021
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-<i>a</i>]pyridine Scaffold: SAR of the Biphenyl MoietyStefano Sainas, Marta Giorgis, Paola Circosta, et al.
Journal of Medicinal Chemistry|September 26, 2022
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-<i>a</i>]pyridine Scaffold: SAR of the Aryloxyaryl MoietyStefano Sainas, Marta Giorgis, Paola Circosta, et al.
Pageof 2